Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female Subjects

Completed · Phase 1

Conditions studied: Healthy Female Volunteer

In brief

Relative Bioavailability study of D-0502 tablet formulation in healthy female subjects

Key facts

Study ID

NCT05226338

Run by

InventisBio Co., Ltd

People needed

18

Starts

2021-10-27

Expected to finish

2022-05-11

Last updated by the study team

2022-08-08

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Healthy female subjects between the ages of 18-55
• Required evaluation by Investigator for screening and enrollment
• Agreement and compliance with the study and follow-up procedures

You may not qualify if…

• Significant medical history or current comorbidly determined by the Investigator.
• Pregnant or nursing women

Where it is running

• Labcorp Clinical Research Unit — Daytona Beach, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.